⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Cytokine-Targeted Biologics (IL-1β, IL-6, TNF-α)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-03 — IL-21R blockade reduces inflammation and atherosclerosis in LDL receptor deficient mice.: cross-connection with il-21r-blockade: Both target cytokine signaling to dampen chronic inflammation relevant to aging-related disease; IL-21R blockade extends the cytokine-biologic concept beyond IL-1β/IL-6/TNF-α to a T-cell helper axis implicated in atherosclerosis. (novelty: 3)
Open questions
Related
Contributing findings
Therapeutic Targeting of Inflammaging and Emerging Strategies for Managing Age-Related Multimorbidity: A Narrative Review.
19-sep-2026
novelty 2
per-area 2
introduces